“Bonzyme”Whole-enzymatic method, environmental-friendly
“Bonzyme”Whole-enzymatic method, environmental-friendly

“Bonzyme”Whole-enzymatic method, environmental-friendly

Supplier of NMN Raw Materials for
Anti-aging Research in CELL Journal

Bontac keeps cultivating deeply on the field of green biosynthesis of coenzymes and nature products

Bontac is the first enterprise in the world to achieve mass production of NMN

Our Products

Product Display

NAD-ER GRADE

NAD-ER GRADE

CAS No.: 53-84-9
Purity: ≥99%

NR-Malate

NR-Malate

CAS No.:2415659-01-5
Purity:≥97.0%

NMNH

NMNH

CAS No.: 108347-85-9
Purity: ≥99.5%

NAD

NAD

CAS No.: 53-84-9
Purity: ≥99%

 NADH

NADH

CAS No.: 606-68-8
Purity: ≥98%

Stevia Sweetener (RD)

Stevia Sweetener (RD)

CAS No.: 63279-13-0
Purity: ≥95%

 NADPH

NADPH

CAS No.:2646-71-7
Purity: ≥95%

S-NAD

S-NAD

CAS No.: 4090-29-3
Purity: ≥ 95%

BONTAC is the Leader of Global Industry

What We Do

Bontac Bio-Engineering (Shenzhen) Co., Ltd. (hereafter referred to as BONTAC) is a high-tech enterprise established in July 2012. BONTAC integrates R&D, production and sales, with enzyme catalysis technology as the core and coenzyme and natural products as main products. There are six major series of products in BONTAC, involving coenzymes, natural products, sugar substitutes, cosmetics, dietary supplements and medical intermediates.

As the leader of the global NMN industry, BONTAC has the first whole-enzyme catalysis technology in China. Our coenzyme products are widely used in
 fields such as nutrition and health, biomedicine, medical beauty, daily chemical and green agriculture. BONTAC adheres to independent innovation, with more than 180 invention patents. Different from the traditional chemical synthesis and fermentation industry, BONTAC has advantages of green low-carbon and high-value-added biosynthesis technology. What’s more, BONTAC has established the first coenzyme engineering technology research center at the provincial level in China which also is the sole in Guangdong Province.

In the future, BONTAC will focus on its advantages of green, low-carbon and high-value-added biosynthesis technology, and build ecological relationship with academia as well as upstream/downstream partners, continuously leading the synthetic biological industry and creating a better life for human beings.
more>>
BONTAC HIGHLIGHT HONORS

Bontac lnternational Patents

20

NMN Patent

90

Honor Certificate

180

Invention Patent

200

More Patents

Why Choose Us

appoinment-img

Inquiry

Our Blog

Latest News

Boost Rumen Health with Steviol Glycosides: One Secret to Healthy Hu Sheep

17 Jul 2024

Boost Rumen Health with Steviol Glycosides: One Secret to Healthy Hu Sheep

Introduction In the realm of animal husbandry, feed additives are necessary as they can not only improve the nutritional value of feed and optimize the internal environment of the rumen, but also enhance

NAD Deficiency: a Treatable Target for HIV-Associated Nephropathy

16 Jul 2024

NAD Deficiency: a Treatable Target for HIV-Associated Nephropathy

Introduction Nicotinamide adenine dinucleotide (NAD) deficiency has been linked to a range of renal disorders, encompassing conditions such as acute kidney injury, diabetic nephropathy, adenine-triggered kidney diseas

Clarifying the Effect of Steviol Glycosides on Glucose Metabolism in Adults

12 Jul 2024

Clarifying the Effect of Steviol Glycosides on Glucose Metabolism in Adults

Introduction In response to the escalating global obesity rates, the demand for sugar reduction has reached a critical juncture. As a strategic pivot, the food industry has increasingly incorporated sugar substitutes,

NR as a Potential Neuroprotective Therapy for Parkinson's Disease

11 Jul 2024

NR as a Potential Neuroprotective Therapy for Parkinson's Disease

Introduction Parkinson's disease (PD), known as the silent killer, has emerged as the second most common chronic neurodegenerative disease in the world after Alzheimer's disease, affecting 

NAD+ Precursor: Regulator of Glucose Metabolism and CRP

10 Jul 2024

NAD+ Precursor: Regulator of Glucose Metabolism and CRP

  Introduction Nicotinamide adenine dinucleotide (NAD+) is a critical coenzyme in cells, a central cofactor of redox reaction and a central regulator of various metabolisms in the human body. It is involved in a

Repairing Effect of Ginsenoside Rh2 on Motor Function After Spinal Cord Injury

09 Jul 2024

Repairing Effect of Ginsenoside Rh2 on Motor Function After Spinal Cord Injury

  Introduction Spinal cord injury (SCI) can lead to severe impairments in motor, sensory, and autonomic nervous system functions. It has been reported that motor function recovery can be promoted by mediatin

Neuroprotective Potential of NR in Ameliorating CCH-Induced Cognitive Impairment

05 Jul 2024

Neuroprotective Potential of NR in Ameliorating CCH-Induced Cognitive Impairment

  Introduction Chronic cerebral hypoperfusion (CCH) has been identified as one of the initial conditions critical to the development of cognitive impairment, which is tightly associated to the complex neurologic

Therapeutic Effects of Biomimetic Liposomes MM-Lip-Rg3/PNS on Ischemic Stroke

04 Jul 2024

Therapeutic Effects of Biomimetic Liposomes MM-Lip-Rg3/PNS on Ischemic Stroke

  Introduction Stroke remains the second leading cause of death and the third leading cause of death and disability combined in the world, as reported in 2019 Global Burden of Disease Study. Ischemic stroke

Pharmacological Effects of Ginsenoside Rg3 on MI/R and the Potential Mechanisms

03 Jul 2024

Pharmacological Effects of Ginsenoside Rg3 on MI/R and the Potential Mechanisms

  Introduction Myocardial ischemia/reperfusion (MI/R) can damage the heart muscle, which may contribute to further cardiomyocyte death. Following percutaneous coronary intervention therapy, patients with MI/

Prophylactic Effects of NMN on Depressive-Like Behaviors

02 Jul 2024

Prophylactic Effects of NMN on Depressive-Like Behaviors

  Introduction According to the report by World Health Organization (WHO) in 2017, depression is the third leading cause of the global disease burden, with over 300 million people suffering from this disease w

Leave Your Message